ADMA Biologics Announces Record Preliminary Fourth Quarter and Full Year 2021 Revenues and Provides 2022 Business UpdateGlobeNewsWire • 01/19/22
ADMA BioCenters Receives FDA Approval for its Fourth Plasma Collection Center Located in Goose Creek, SCGlobeNewsWire • 01/18/22
Implied Volatility Surging for ADMA Biologics (ADMA) Stock OptionsZacks Investment Research • 12/10/21
ADMA Biologics Senior Vice President of Plasma Services Cyndi Tolman Elected to PPTA Source Board of DirectorsGlobeNewsWire • 11/17/21
ADMA Biologics Advances Plasma Collection Center Expansion Plans with Opening of New Facility in Myrtle Beach, SCGlobeNewsWire • 11/16/21
ADMA Biologics, Inc. (ADMA) CEO Adam Grossman on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/11/21
ADMA Biologics Reports Record Third Quarter 2021 Financial Results and Highlights Recent Progress and AccomplishmentsGlobeNewsWire • 11/10/21
ADMA Biologics to Report Third Quarter 2021 Financial Results on November 10, 2021GlobeNewsWire • 11/03/21
Will Adma Biologics (ADMA) Report Negative Q3 Earnings? What You Should KnowZacks Investment Research • 10/28/21
ADMA Biologics Announces Closing of $57.5 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional SharesGlobeNewsWire • 10/25/21
ADMA Biologics Announces Pricing of Public Offering for $50 Million of Common StockGlobeNewsWire • 10/21/21
ADMA Biologics Announces a Poster Presentation at the 2021 International Society for Influenza and other Respiratory Virus Diseases - World Health Organization ConferenceGlobeNewsWire • 10/19/21
ADMA Biologics Strengthens its Board of Directors with the Appointment of Young T. Kwon, Ph.D.GlobeNewsWire • 10/18/21
ADMA Biologics Announces the Presentation of Real-World Experience in the Management of Respiratory Syncytial Virus (RSV) Presented at IDWeek 2021GlobeNewsWire • 10/04/21